COVID-19
COVID-19
“1.5 million children are living with HIV in sub-Saharan Africa. I’m one of the doctors treating these young patients every day”
A relaunched Johnson & Johnson partnership will help ensure that many young patients get lifesaving access to HIV medicines. Meet a doctor in Kenya who explains why the program is so crucial.
Johnson & Johnson ranks #4 on Fortune’s Return on Leadership list
For more than a century, Johnson & Johnson has used a core set of values to help build its business. Now, that sense of purpose has landed it on the Fortune ROL100, a new ranking of corporate leadership.
5 ways Johnson & Johnson is working to improve the well-being of the world by 2025
Johnson & Johnson’s 2020 Health for Humanity Report details the progress it’s made in the past five years in driving sustainable social, environmental and economic change around the globe. Now the company’s looking ahead to the next five.
Johnson & Johnson named to the TIME100 Most Influential Companies list
The company is honored to be recognized for its leadership in helping shape the trajectory of healthcare around the world.
2 pandemics, 1 goal: Meet 4 innovators with high-tech ideas for fighting tuberculosis in the time of COVID-19
Despite being preventable and curable, tuberculosis is one of the world’s deadliest infectious diseases—and COVID-19 is making it even harder to diagnose and treat it. Enter these healthcare visionaries, who’ve made it their mission to move the world closer to the goal of ending tuberculosis.
One year later: The head of Johnson & Johnson China looks back on what we’ve learned from the pandemic—and how it can help shape the future
Will Song’s teams were on the front lines when COVID-19 shut down the city of Wuhan. One year to the day that the World Health Organization declared the disease a pandemic, he shares how the company kept going during the crisis and the innovative ideas that emerged from it.
Johnson & Johnson Chairman and CEO appears at the White House to discuss the company’s collaboration with Merck and future vaccine production
Learn more about the event, Johnson & Johnson’s historic collaboration with Merck—and watch a video that chronicles the progress that the company has made since last March in the fight against COVID-19.
From lab to vaccine vial: The historic manufacturing journey of Johnson & Johnson’s Janssen COVID-19 Vaccine
As the U.S. government announces an agreement between Johnson & Johnson and Merck to collaborate on vaccine production, we trace all the steps it takes—from growing cells in a bioreactor to prepping palettes with high-tech track-and-trace technology—to develop and manufacture a vaccine during a pandemic.
A message from Chairman and CEO Alex Gorsky about the Emergency Use Authorization of Johnson & Johnson’s Janssen COVID-19 vaccine
The company leader shares the latest news about the U.S. Food and Drug Administration’s decision about the single-shot Janssen COVID-19 vaccine.
8 things to know about Johnson & Johnson’s Janssen COVID-19 Vaccine
As the company announces that its single-dose Janssen COVID-19 Vaccine has been granted Emergency Use Authorization by the U.S. Food and Drug Administration, here are some key facts about how it works (hint: it involves an inactivated common cold virus), how it has been studied, how it would be transported—and more.